Seattle's $1.5B Q1 2026: Fewer Deals, Bigger Checks, AI Dominates
Seattle's Q1 2026 saw 69 deals for $1.5B — the lowest deal count since mid-2020, reflecting a national AI-led capital concentration trend.
Venture capital fuels the companies that reshape industries — from AI infrastructure and fintech to healthcare and defense tech. This hub collects our latest analysis on how VC firms evaluate startups, structure deals, and deploy capital across stages and geographies.
Browse the articles below to research investors, understand deal dynamics, and build a sharper fundraising strategy.
Seattle's Q1 2026 saw 69 deals for $1.5B — the lowest deal count since mid-2020, reflecting a national AI-led capital concentration trend.
Seattle-based Temporal's Series D shows that orchestration, retries, and state management are becoming core AI infrastructure — not nice-to-haves.
EUVC Summit & Awards on April 22 in London is one of the few EU events where LP allocations and GP relationships genuinely progress.
Imaginary Ventures led a $1.5M seed in bioactive skincare startup Sweet Chemistry and an $11M Series A for regenerative-dairy brand Alec’s Ice Cream.
The 0100 Europe gathering on April 21–23 remains one of Europe's most pragmatic venues for GP-LP relationships and private markets deal talk.
A pragmatic 2026 map of NYC's most active seed and pre-seed investors — and what they actually fund.